Compare Free Cash Flow Per Share Across Equities
You can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible positions. Check out your portfolio center.
Cross Equities Free Cash Flow Per Share Analysis
Select Fundamental
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DTE | 3.3433 | 3.1006 | 2.2749 | 1.5886 | (1.1864) | (0.6089) | 0.2179 | (0.743) | (0.1823) | (1.8811) | (0.829) | (3.6528) | (7.1846) | (3.466) | (3.29) |
| AEE | 3.2547 | 1.4798 | 1.4798 | 1.1088 | (1.2696) | 0.1979 | (0.033) | (0.3751) | (0.6891) | (1.1075) | (6.3644) | (7.2649) | (4.3228) | (4.5928) | (4.36) |
| CNP | 2.8177 | 1.3732 | 1.5176 | 0.764 | 0.0582 | 0.6538 | 1.1937 | (0.0116) | 1.0806 | (1.7289) | (1.1318) | (5.2991) | (4.1451) | (0.8304) | (0.79) |
| PNW | 2.7674 | 2.2121 | 2.5712 | 1.2455 | 1.7084 | 0.1643 | (2.2627) | (2.5996) | 0.8827 | (2.0875) | (3.1972) | (5.4332) | (4.1172) | (5.63) | (5.35) |
| CMS | 0.432 | 1.1443 | (0.1343) | 0.1509 | (0.7565) | (0.0471) | (0.5396) | (0.2679) | (1.832) | (1.576) | (4.1123) | (1.3495) | (5.6166) | (0.91) | (0.96) |
| IDA | 0.4036 | (0.5565) | 0.1904 | 1.4033 | 1.8003 | 1.1783 | 1.0091 | 3.0288 | 4.2388 | 1.7409 | 1.5274 | 1.2503 | (1.605) | (6.7849) | (6.45) |
DTE Energy, Ameren Corp, and CenterPoint Energy Free Cash Flow Per Share description
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.Use Investing Themes to Complement your positions
You can quickly originate your optimal portfoio using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |